The industrial giant Siemens continues to produce record operational results and has secured major strategic AI contracts from the U.S. government. However, the capital market’s reaction has been notably tepid, even in the face of an upgraded annual forecast and a robust order backlog. Investor attention appears fixated on the looming historic corporate restructuring, which is overshadowing the underlying growth narrative.
Market Skepticism Meets Operational Power
Siemens’s technological leadership is backed by strong fundamentals. The company recently reported its first-quarter 2026 figures, which were uniformly robust:
- New Orders: €21.4 billion (a 10% increase)
- Revenue: €19.1 billion (an 8% increase)
- Adjusted Earnings Per Share (EPS): €2.80 (compared to €2.22 the previous year)
- New Full-Year EPS Guidance: €10.70 to €11.10
A significant driver has been immense U.S. demand for cloud and AI infrastructure, which propelled a 35% revenue surge in the data center business. Yet, the equity currently trades at €223.10, marking a decline of more than 13% over the past 30 days. This disconnect between operational excellence and weak share price performance is largely attributed to uncertainty surrounding the group’s future structure.
Strategic Moves and Management Transition
The planned reduction of Siemens’s stake in Siemens Healthineers is causing investor hesitation. Management intends to spin off approximately 30% of the medical technology subsidiary directly to its shareholders, thereafter treating the remaining holding as a pure financial investment. The lack of detailed plans for this complex maneuver has created a cloud of uncertainty.
Compounding this is an impending management change. Long-time CFO Ralf P. Thomas will hand over his role to Veronika Bienert on April 1. Financial markets traditionally view such transition periods with caution, even as a substantial share buyback program provides underlying support. Of the authorized €6 billion, €4.4 billion has already been deployed, with the company set to retire a further 18 million of its own shares this month.
Amidst this, Siemens is advancing strategically. The group just signed a key agreement with the U.S. Department of Energy under the “Genesis Mission,” which will see it supply domain-specific AI and digital twin technology to modernize American research infrastructure. Concurrently, the company is automating its own manufacturing, partnering with Nvidia to establish fully AI-controlled model factories in Erlangen and Amberg by 2030. The integration of U.S. software provider Altair is also providing a noticeable tailwind for the high-margin digital business.
Awaiting Clarity on Restructuring
The current structural limbo is expected to resolve in the coming weeks. CEO Roland Busch has promised concrete details regarding the tax and timing structure of the Healthineers spin-off early in the second calendar quarter. By the time the next quarterly figures are presented on May 13, the market will have begun to assess whether the thriving industrial operations can sufficiently offset the short-term risks associated with this corporate transformation.